Belmont Global Advisors’s Fate Therapeutics FATE Stock Holding History

Belmont Global Advisors’s Portfolio FATE Stock Details FATE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$468K	Sell	150,000 -250,000	-63%	-$607K	0.83%	45
2016 Q2	$680K	Sell	400,000 -82,000	-17%	-$149K	1.31%	30
2016 Q1	$868K	Buy	482,000 +317,000	+192%	+$653K	1.55%	26
2015 Q4	$556K	Buy	+165,000	New	+$694K	0.9%	43

Other funds holding FATE

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return

Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Lombard Odier Asset Management (USA) New York $186M AUM 35.8% 1-Year Est. Return